UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 374

Sortiert nach

Molecularly targeted therapy for hepatocellular carcinoma

Cancer science, 2009-01, Vol.100 (1), p.1-8

2009

Link zum Volltext

Verfügbarkeit prüfen

Molecular Targeted Therapies in Hepatocellular Carcinoma

Seminars in oncology, 2012-08, Vol.39 (4), p.486-492

2012

Link zum Volltext

Verfügbarkeit prüfen

miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma

Carcinogenesis (New York), 2010-05, Vol.31 (5), p.766-776

2010

Link zum Volltext

Verfügbarkeit prüfen

Evidence-based Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2013 update (3rd JSH-HCC Guidelines)

Hepatology research, 2015-02, Vol.45 (2), p.n/a

2015

Link zum Volltext

Verfügbarkeit prüfen

Molecular targeted therapy for hepatocellular carcinoma in the current and potential next strategies

Journal of gastroenterology, 2011-03, Vol.46 (3), p.289-296

2011

Link zum Volltext

Verfügbarkeit prüfen

Report of the 17th Nationwide Follow-up Survey of Primary Liver Cancer in Japan

Hepatology research, 2007-09, Vol.37 (9), p.676-691

2007

Link zum Volltext

Verfügbarkeit prüfen

The tumor-suppressive miR-497-195 cluster targets multiple cell-cycle regulators in hepatocellular carcinoma

PloS one, 2013-03, Vol.8 (3), p.e60155

2013

Link zum Volltext

Verfügbarkeit prüfen

Development of evidence‐based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan

Hepatology research, 2008-01, Vol.38 (1), p.37-51

2008

Link zum Volltext

Verfügbarkeit prüfen

Management of hepatocellular carcinoma: Report of Consensus Meeting in the 45th Annual Meeting of the Japan Society of Hepatology (2009)

Hepatology research, 2010-07, Vol.40 (7), p.667-685

2010

Link zum Volltext

Verfügbarkeit prüfen

Superselective transarterial chemoembolization for hepatocellular carcinoma. Validation of treatment algorithm proposed by Japanese guidelines

Journal of hepatology, 2012-04, Vol.56 (4), p.886-892

2012

Link zum Volltext

Verfügbarkeit prüfen

Report of the 18th follow-up survey of primary liver cancer in Japan

Hepatology Research, 2010-11, Vol.40 (11), p.1043-1059

2010

Link zum Volltext

Verfügbarkeit prüfen

Comparison of the outcomes between an anatomical subsegmentectomy and a non-anatomical minor hepatectomy for single hepatocellular carcinomas based on a Japanese nationwide survey

Surgery, 2008-04, Vol.143 (4), p.469-475

2008

Link zum Volltext

Verfügbarkeit prüfen

Prospective Cohort Study of Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma in 8510 Patients

Gastroenterology (New York, N.Y. 1943), 2006-08, Vol.131 (2), p.461-469

2006

Link zum Volltext

Verfügbarkeit prüfen

Dominant Expression of DCLK1 in Human Pancreatic Cancer Stem Cells Accelerates Tumor Invasion and Metastasis

PloS one, 2016-01, Vol.11 (1), p.e0146564-e0146564

2016

Link zum Volltext

Verfügbarkeit prüfen

Hypervascular hepatocellular carcinoma: correlation between biologic features and signal intensity on gadoxetic acid-enhanced MR images

Radiology, 2012-12, Vol.265 (3), p.780

2012

Link zum Volltext

Verfügbarkeit prüfen

Gd‐EOB‐DTPA‐enhanced magnetic resonance imaging and alpha‐fetoprotein predict prognosis of early‐stage hepatocellular carcinoma

Hepatology (Baltimore, Md.), 2014-11, Vol.60 (5), p.1674-1685

2014

Link zum Volltext

Verfügbarkeit prüfen

FGF3/FGF4 amplification and multiple lung metastases in responders to sorafenib in hepatocellular carcinoma

Hepatology (Baltimore, Md.), 2013-04, Vol.57 (4), p.1407-1415

2013

Link zum Volltext

Verfügbarkeit prüfen

Acquired Resistance with Epigenetic Alterations Under Long-Term Antiangiogenic Therapy for Hepatocellular Carcinoma

Molecular cancer therapeutics, 2017-06, Vol.16 (6), p.1155-1165

2017

Link zum Volltext

Verfügbarkeit prüfen

Anatomic resection reduces the recurrence of solitary hepatocellular carcinoma ≤5 cm without macrovascular invasion

The American journal of surgery, 2014-06, Vol.207 (6), p.863-869

2014

Link zum Volltext

Verfügbarkeit prüfen

Surgeons' involvement in COVID-19 treatment: a practice by a regional core hospital in Japan to avoid physician burnout

BMC health services research, 2023-01, Vol.23 (1), p.28-10, Article 28

2023

Link zum Volltext

Verfügbarkeit prüfen

Epigenetic silencing of miR-335 and its host gene MEST in hepatocellular carcinoma

International journal of oncology, 2013-02, Vol.42 (2), p.411-418

2013

Link zum Volltext

Verfügbarkeit prüfen

The safety and feasibility of laparoscopic gastrectomy for gastric cancer in very elderly patients: short-and long-term outcomes

Surgery today (Tokyo, Japan), 2021-02, Vol.51 (2), p.219-225

2021

Link zum Volltext

Verfügbarkeit prüfen

Molecularly targeted therapy for hepatocellular carcinoma from the basic and clinical aspects

International journal of clinical oncology, 2010-06, Vol.15 (3), p.234-234

Arii, Shigeki

2010

Link zum Volltext

Verfügbarkeit prüfen

Current status of molecularly targeted therapy for hepatocellular carcinoma: basic science

International journal of clinical oncology, 2010-06, Vol.15 (3), p.235-241

2010

Link zum Volltext

Verfügbarkeit prüfen

Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: A retrospective and nationwide survey in Japan

Hepatology (Baltimore, Md.), 2000-12, Vol.32 (6), p.1224-1229

2000

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 374

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(326)
Mit Volltextzugriff
(324)

Publikationsform

Sprache

Englisch
(319)
Japanisch
(166)

Erscheinungsjahr

n.n

Thema

Science & Technology
(225)
Life Sciences & Biomedicine
(219)
Humans
(189)
Male
(144)
Biological And Medical Sciences
(106)
Medical Sciences
(101)
Female
(97)
Animals
(90)
Surgery
(90)
Middle Aged
(81)
Gastroenterology & Hepatology
(79)
Aged
(78)
Tumors
(72)
Liver Neoplasms - Pathology
(69)
Hepatocellular Carcinoma
(67)
Carcinoma, Hepatocellular - Pathology
(63)
Gastroenterology. Liver. Pancreas. Abdomen
(63)
Oncology
(62)
Liver. Biliary Tract. Portal Circulation. Exocrine Pancreas
(52)
Rats
(49)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Molecularly targeted therapy for hepatocellular carcinoma

Molecular Targeted Therapies in Hepatocellular Carcinoma

miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma

Evidence-based Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2013 update (3rd JSH-HCC Guidelines)

Molecular targeted therapy for hepatocellular carcinoma in the current and potential next strategies

Report of the 17th Nationwide Follow-up Survey of Primary Liver Cancer in Japan

The tumor-suppressive miR-497-195 cluster targets multiple cell-cycle regulators in hepatocellular carcinoma

Development of evidence‐based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan

Management of hepatocellular carcinoma: Report of Consensus Meeting in the 45th Annual Meeting of the Japan Society of Hepatology (2009)

Superselective transarterial chemoembolization for hepatocellular carcinoma. Validation of treatment algorithm proposed by Japanese guidelines

Report of the 18th follow-up survey of primary liver cancer in Japan

Comparison of the outcomes between an anatomical subsegmentectomy and a non-anatomical minor hepatectomy for single hepatocellular carcinomas based on a Japanese nationwide survey

Prospective Cohort Study of Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma in 8510 Patients

Dominant Expression of DCLK1 in Human Pancreatic Cancer Stem Cells Accelerates Tumor Invasion and Metastasis

Hypervascular hepatocellular carcinoma: correlation between biologic features and signal intensity on gadoxetic acid-enhanced MR images

Gd‐EOB‐DTPA‐enhanced magnetic resonance imaging and alpha‐fetoprotein predict prognosis of early‐stage hepatocellular carcinoma

FGF3/FGF4 amplification and multiple lung metastases in responders to sorafenib in hepatocellular carcinoma

Acquired Resistance with Epigenetic Alterations Under Long-Term Antiangiogenic Therapy for Hepatocellular Carcinoma

Anatomic resection reduces the recurrence of solitary hepatocellular carcinoma ≤5 cm without macrovascular invasion

Surgeons' involvement in COVID-19 treatment: a practice by a regional core hospital in Japan to avoid physician burnout

Epigenetic silencing of miR-335 and its host gene MEST in hepatocellular carcinoma

The safety and feasibility of laparoscopic gastrectomy for gastric cancer in very elderly patients: short-and long-term outcomes

Molecularly targeted therapy for hepatocellular carcinoma from the basic and clinical aspects

Current status of molecularly targeted therapy for hepatocellular carcinoma: basic science

Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: A retrospective and nationwide survey in Japan

Suchergebnisse filtern